ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $120,903,000 | -12.8% | 10,272,054 | +1.1% | 0.03% | -12.9% |
| Q1 2019 | $138,672,000 | +183.9% | 10,159,082 | +113.2% | 0.03% | +158.3% |
| Q4 2018 | $48,843,000 | -29.1% | 4,765,123 | +15.1% | 0.01% | -20.0% |
| Q3 2018 | $68,934,000 | -11.0% | 4,140,169 | -15.5% | 0.02% | -11.8% |
| Q2 2018 | $77,420,000 | +22.2% | 4,899,955 | -1.8% | 0.02% | +21.4% |
| Q1 2018 | $63,354,000 | +22.5% | 4,988,478 | +10.5% | 0.01% | +27.3% |
| Q4 2017 | $51,697,000 | -14.1% | 4,515,093 | -8.1% | 0.01% | -21.4% |
| Q3 2017 | $60,183,000 | +46.1% | 4,912,870 | +36.6% | 0.01% | +40.0% |
| Q2 2017 | $41,188,000 | -45.6% | 3,597,231 | -1.2% | 0.01% | -44.4% |
| Q1 2017 | $75,728,000 | +0.7% | 3,640,788 | +0.7% | 0.02% | -5.3% |
| Q4 2016 | $75,170,000 | -40.2% | 3,613,997 | -5.8% | 0.02% | -38.7% |
| Q3 2016 | $125,714,000 | +14.9% | 3,836,272 | -12.4% | 0.03% | +10.7% |
| Q2 2016 | $109,367,000 | +41.5% | 4,379,963 | +38.7% | 0.03% | +40.0% |
| Q1 2016 | $77,310,000 | +72.9% | 3,156,865 | +133.2% | 0.02% | +66.7% |
| Q4 2015 | $44,715,000 | +3350.2% | 1,353,755 | +3323.0% | 0.01% | – |
| Q3 2015 | $1,296,000 | -45.8% | 39,549 | -12.4% | 0.00% | -100.0% |
| Q2 2015 | $2,393,000 | -63.7% | 45,169 | -80.2% | 0.00% | -50.0% |
| Q1 2015 | $6,585,000 | -26.5% | 228,169 | -26.0% | 0.00% | 0.0% |
| Q4 2014 | $8,965,000 | +191.6% | 308,189 | +27.1% | 0.00% | +100.0% |
| Q3 2014 | $3,074,000 | -1.1% | 242,419 | +56.5% | 0.00% | 0.0% |
| Q2 2014 | $3,109,000 | – | 154,919 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |